Published in Proc Natl Acad Sci U S A on February 27, 2001
A role for brain stress systems in addiction. Neuron (2008) 4.71
Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci U S A (2001) 3.23
Brain stress systems in the amygdala and addiction. Brain Res (2009) 2.14
Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets. CNS Neurol Disord Drug Targets (2006) 1.97
The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues Clin Neurosci (2006) 1.96
Molecular recognition of corticotropin-releasing factor by its G-protein-coupled receptor CRFR1. J Biol Chem (2008) 1.94
The Creb1 coactivator Crtc1 is required for energy balance and fertility. Nat Med (2008) 1.87
NMR structure and peptide hormone binding site of the first extracellular domain of a type B1 G protein-coupled receptor. Proc Natl Acad Sci U S A (2004) 1.80
Corticotropin-releasing factor receptors and stress-related alterations of gut motor function. J Clin Invest (2007) 1.77
Key role of CRF in the skin stress response system. Endocr Rev (2013) 1.77
The role of CRF and CRF-related peptides in the dark side of addiction. Brain Res (2009) 1.74
Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs. Front Neuroendocrinol (2006) 1.60
Local secretion of urocortin 1 promotes microvascular permeability during lipopolysaccharide-induced inflammation. Endocrinology (2009) 1.49
Differential expression of a cutaneous corticotropin-releasing hormone system. Endocrinology (2003) 1.46
Central CRF, urocortins and stress increase colonic transit via CRF1 receptors while activation of CRF2 receptors delays gastric transit in mice. J Physiol (2004) 1.45
CRF1 receptor signaling pathways are involved in stress-related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndrome. Br J Pharmacol (2004) 1.44
Role of corticotropin releasing factor in anxiety disorders: a translational research perspective. Horm Behav (2006) 1.43
The CRF system, stress, depression and anxiety-insights from human genetic studies. Mol Psychiatry (2009) 1.43
The MC4 receptor and control of appetite. Br J Pharmacol (2006) 1.41
Expression of urocortin peptides in canine myocardium and plasma. Vet J (2010) 1.37
Corticotrophin-releasing factor receptors within the ventromedial hypothalamus regulate hypoglycemia-induced hormonal counterregulation. J Clin Invest (2006) 1.30
Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval. Neuropsychopharmacology (2006) 1.27
Role of peripheral corticotropin-releasing factor and urocortin II in intestinal inflammation and motility in terminal ileum. Proc Natl Acad Sci U S A (2005) 1.25
The cardiovascular physiologic actions of urocortin II: acute effects in murine heart failure. Proc Natl Acad Sci U S A (2004) 1.22
Neuroendocrine control of the gut during stress: corticotropin-releasing factor signaling pathways in the spotlight. Annu Rev Physiol (2009) 1.19
Corticotropin-releasing factor signaling and visceral response to stress. Exp Biol Med (Maywood) (2010) 1.18
Augmented cocaine seeking in response to stress or CRF delivered into the ventral tegmental area following long-access self-administration is mediated by CRF receptor type 1 but not CRF receptor type 2. J Neurosci (2011) 1.13
Urocortin 1 microinjection into the mouse lateral septum regulates the acquisition and expression of alcohol consumption. Neuroscience (2007) 1.12
Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice. Psychopharmacology (Berl) (2003) 1.11
Corticotropin-releasing factor in the dorsal raphe nucleus: Linking stress coping and addiction. Brain Res (2009) 1.10
Brain-Gut Interactions in IBS. Front Pharmacol (2012) 1.10
Structural basis for hormone recognition by the Human CRFR2{alpha} G protein-coupled receptor. J Biol Chem (2010) 1.08
A soluble mouse brain splice variant of type 2alpha corticotropin-releasing factor (CRF) receptor binds ligands and modulates their activity. Proc Natl Acad Sci U S A (2005) 1.08
Urocortin 2 modulates glucose utilization and insulin sensitivity in skeletal muscle. Proc Natl Acad Sci U S A (2006) 1.08
Stress-related neuropeptides and addictive behaviors: beyond the usual suspects. Neuron (2012) 1.06
Activation of brain somatostatin 2 receptors stimulates feeding in mice: analysis of food intake microstructure. Physiol Behav (2010) 1.06
Urocortin II mediates pro-inflammatory effects in human colonocytes via corticotropin-releasing hormone receptor 2alpha. Gut (2007) 1.05
Cortagine, a specific agonist of corticotropin-releasing factor receptor subtype 1, is anxiogenic and antidepressive in the mouse model. Proc Natl Acad Sci U S A (2004) 1.04
Feeding microstructure in diet-induced obesity susceptible versus resistant rats: central effects of urocortin 2. J Physiol (2007) 1.03
Corticotropin-releasing factor receptor 2 is a tonic suppressor of vascularization. Proc Natl Acad Sci U S A (2002) 1.03
On the role of the corticotropin-releasing hormone signalling system in the aetiology of inflammatory skin disorders. Br J Dermatol (2009) 1.02
CRF2 receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilators. Br J Pharmacol (2004) 1.02
Stressin1-A, a potent corticotropin releasing factor receptor 1 (CRF1)-selective peptide agonist. J Med Chem (2007) 1.01
Role of Corticotropin-releasing Factor Signaling in Stress-related Alterations of Colonic Motility and Hyperalgesia. J Neurogastroenterol Motil (2015) 1.01
Urocortin-induced endothelium-dependent relaxation of rat coronary artery: role of nitric oxide and K+ channels. Br J Pharmacol (2002) 0.98
The highly selective CRF(2) receptor antagonist K41498 binds to presynaptic CRF(2) receptors in rat brain. Br J Pharmacol (2002) 0.98
Activation of raphe efferents to the medial prefrontal cortex by corticotropin-releasing factor: correlation with anxiety-like behavior. Biol Psychiatry (2007) 0.97
Insights into mechanisms of corticotropin-releasing hormone receptor signal transduction. Br J Pharmacol (2012) 0.97
Corticotropin-releasing hormone family of peptides regulates intestinal angiogenesis. Gastroenterology (2010) 0.97
Emerging role of alternative splicing of CRF1 receptor in CRF signaling. Acta Biochim Pol (2010) 0.97
Central urocortin 3 administration decreases limited-access ethanol intake in nondependent mice. Behav Pharmacol (2009) 0.97
Urocortins: CRF's siblings and their potential role in anxiety, depression and alcohol drinking behavior. Alcohol (2012) 0.94
Footshock-induced urinary bladder hypersensitivity: role of spinal corticotropin-releasing factor receptors. J Pain (2008) 0.94
Dissection of corticotropin-releasing factor system involvement in locomotor sensitivity to methamphetamine. Genes Brain Behav (2010) 0.93
Both corticotropin-releasing factor receptor type 1 and type 2 are involved in stress-induced inhibition of food intake in rats. Psychopharmacology (Berl) (2004) 0.92
Preclinical evidence implicating corticotropin-releasing factor signaling in ethanol consumption and neuroadaptation. Genes Brain Behav (2015) 0.92
Cardiovascular responses to microinjections of urocortin 3 into the nucleus tractus solitarius of the rat. Am J Physiol Heart Circ Physiol (2008) 0.92
Chronic low dose ovine corticotropin releasing factor or urocortin II into the rostral dorsal raphe alters exploratory behavior and serotonergic gene expression in specific subregions of the dorsal raphe. Neuroscience (2007) 0.92
A triple urocortin knockout mouse model reveals an essential role for urocortins in stress recovery. Proc Natl Acad Sci U S A (2010) 0.92
From Hans Selye's discovery of biological stress to the identification of corticotropin-releasing factor signaling pathways: implication in stress-related functional bowel diseases. Ann N Y Acad Sci (2008) 0.91
Identifying the stress transcriptome in the adrenal medulla following acute and repeated immobilization. Ann N Y Acad Sci (2008) 0.90
Peripheral activation of corticotropin-releasing factor receptor 2 inhibits food intake and alters meal structures in mice. Peptides (2010) 0.90
Trends in the development of new antidepressants. Is there a light at the end of the tunnel? Curr Med Chem (2004) 0.90
CRF and urocortin peptides as modulators of energy balance and feeding behavior during stress. Front Neurosci (2014) 0.89
A novel corticotropin-releasing factor receptor splice variant exhibits dominant negative activity: a putative link to stress-induced heart disease. FASEB J (2009) 0.89
Blocking corticotropin-releasing factor-2 receptors, but not corticotropin-releasing factor-1 receptors or glucocorticoid feedback, disrupts the development of conditioned defeat. Physiol Behav (2010) 0.89
The CRF system and social behavior: a review. Front Neurosci (2013) 0.88
A molecular census of arcuate hypothalamus and median eminence cell types. Nat Neurosci (2017) 0.88
Corticotropin-releasing factor-related peptides, serotonergic systems, and emotional behavior. Front Neurosci (2013) 0.88
Intracisternal urocortin inhibits vagally stimulated gastric motility in rats: role of CRF(2). Br J Pharmacol (2002) 0.88
Central corticotropin releasing factor and social stress. Front Neurosci (2013) 0.88
Urocortin-deficient mice display normal stress-induced anxiety behavior and autonomic control but an impaired acoustic startle response. Mol Cell Biol (2002) 0.87
Comparison of CRF-immunoreactive neurons distribution in mouse and rat brains and selective induction of Fos in rat hypothalamic CRF neurons by abdominal surgery. Brain Res (2011) 0.86
CRF1 receptor activation increases the response of neurons in the basolateral nucleus of the amygdala to afferent stimulation. Front Behav Neurosci (2008) 0.86
Type 2 corticotropin-releasing factor receptor in the ventromedial nucleus of hypothalamus is critical in regulating feeding and lipid metabolism in white adipose tissue. Endocrinology (2011) 0.86
cAMP- and Ca²(+) /calmodulin-dependent protein kinases mediate inotropic, lusitropic and arrhythmogenic effects of urocortin 2 in mouse ventricular myocytes. Br J Pharmacol (2011) 0.86
Chronic and acute effects of stress on energy balance: are there appropriate animal models? Am J Physiol Regul Integr Comp Physiol (2014) 0.86
Urocortin 3 transgenic mice exhibit a metabolically favourable phenotype resisting obesity and hyperglycaemia on a high-fat diet. Diabetologia (2011) 0.86
Region-specific roles of the corticotropin-releasing factor-urocortin system in stress. Nat Rev Neurosci (2016) 0.85
Residue 17 of sauvagine cross-links to the first transmembrane domain of corticotropin-releasing factor receptor 1 (CRFR1). J Biol Chem (2008) 0.85
Urocortin 2 increases c-Fos expression in serotonergic neurons projecting to the ventricular/periventricular system. Exp Neurol (2010) 0.85
Microinjections of urocortin1 into the nucleus ambiguus of the rat elicit bradycardia. Am J Physiol Heart Circ Physiol (2010) 0.85
Bradycardic effects of microinjections of urocortin 3 into the nucleus ambiguus of the rat. Am J Physiol Regul Integr Comp Physiol (2012) 0.85
Behavioral Studies and Genetic Alterations in Corticotropin-Releasing Hormone (CRH) Neurocircuitry: Insights into Human Psychiatric Disorders. Behav Sci (Basel) (2012) 0.85
On the role of corticotropin-releasing hormone receptors in anxiety and depression. Dialogues Clin Neurosci (2002) 0.84
Altered maternal profiles in corticotropin-releasing factor receptor 1 deficient mice. BMC Neurosci (2007) 0.83
Stress and addiction: contribution of the corticotropin releasing factor (CRF) system in neuroplasticity. Front Mol Neurosci (2012) 0.83
Chronic activation of corticotropin-releasing factor type 2 receptors reveals a key role for 5-HT1A receptor responsiveness in mediating behavioral and serotonergic responses to stressful challenge. Biol Psychiatry (2012) 0.83
Central mediators involved in the febrile response: effects of antipyretic drugs. Temperature (Austin) (2015) 0.83
Is it really a matter of simple dualism? Corticotropin-releasing factor receptors in body and mental health. Front Endocrinol (Lausanne) (2013) 0.83
Mouse strain differences in the effects of corticotropin releasing hormone (CRH) on sleep and wakefulness. Brain Res (2007) 0.82
Topographical distribution of corticotropin-releasing factor type 2 receptor-like immunoreactivity in the rat dorsal raphe nucleus: co-localization with tryptophan hydroxylase. Neuroscience (2011) 0.82
Corticotrophin-releasing factor, related peptides, and receptors in the normal and inflamed gastrointestinal tract. Front Neurosci (2011) 0.81
Teneurin C-terminal associated peptides (TCAP): modulators of corticotropin-releasing factor (CRF) physiology and behavior. Front Neurosci (2013) 0.81
Expression and functional characterization of membrane-integrated mammalian corticotropin releasing factor receptors 1 and 2 in Escherichia coli. PLoS One (2014) 0.81
NFAT transcription factor regulation by urocortin II in cardiac myocytes and heart failure. Am J Physiol Heart Circ Physiol (2014) 0.81
Expression, binding, and signaling properties of CRF2(a) receptors endogenously expressed in human retinoblastoma Y79 cells: passage-dependent regulation of functional receptors. J Neurochem (2007) 0.81
Systemic urocortin 2, but not urocortin 1 or stressin 1-A, suppresses feeding via CRF2 receptors without malaise and stress. Br J Pharmacol (2011) 0.81
Intermale aggression in corticotropin-releasing factor receptor 1 deficient mice. Behav Brain Res (2006) 0.81
Corticotropin-releasing factor receptor type 1 and type 2 interaction in irritable bowel syndrome. J Gastroenterol (2015) 0.81
Hidden Markov models. Curr Opin Struct Biol (1996) 11.56
Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science (1981) 9.64
Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology (1983) 4.67
Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature (1995) 4.24
Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol (2000) 4.17
Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. Annu Rev Neurosci (1983) 3.98
Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron (1998) 3.08
Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet (2000) 3.04
Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci (1995) 3.04
Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat Genet (2000) 2.24
Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci U S A (1994) 2.14
Unraveling the central nervous system pathways underlying responses to leptin. Nat Neurosci (1998) 2.08
Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies. Synapse (1996) 1.97
Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science (1996) 1.91
Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nat Genet (2000) 1.90
Modulation of urocortin-induced hypophagia and weight loss by corticotropin-releasing factor receptor 1 deficiency in mice. Endocrinology (2000) 1.72
Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors. J Comp Neurol (1999) 1.57
The functional neuroanatomy of corticotropin-releasing factor. Ciba Found Symp (1993) 1.52
Do centrally administered neuropeptides access cognate receptors?: an analysis in the central corticotropin-releasing factor system. J Neurosci (2000) 1.49
Spatially and temporally differentiated patterns of c-fos expression in brainstem catecholaminergic cell groups induced by cardiovascular challenges in the rat. J Comp Neurol (1994) 1.47
Neurobiology of corticotropin releasing factor (CRF) receptors and CRF-binding protein: implications for the treatment of CNS disorders. Mol Psychiatry (1996) 1.28
Mismatches between neurotransmitter and receptor localizations in brain: observations and implications. Neuroscience (1987) 1.28
Corticotropin-releasing factor (CRF) and endocrine responses to stress: CRF receptors, binding protein, and related peptides. Proc Soc Exp Biol Med (1997) 1.21
Expression of Fos-like protein in brain following sustained hypertension and hypotension in conscious rabbits. Neuroscience (1994) 1.18
Central connections of the sensory and motor nuclei of the vagus nerve. J Auton Nerv Syst (1983) 1.15
Dissociation of locomotor activation and suppression of food intake induced by CRF in CRFR1-deficient mice. Endocrinology (2000) 1.08
Peptide chemistry: development of high performance liquid chromatography and capillary zone electrophoresis. Biopolymers (1996) 1.07
Conformationally restricted competitive antagonists of human/rat corticotropin-releasing factor. J Med Chem (1994) 1.00
The role of limbic and hypothalamic corticotropin-releasing factor in behavioral responses to stress. Ann N Y Acad Sci (1993) 0.92
Molecular cloning and characterization of the Fugu rubripes MEST/COPG2 imprinting cluster and chromosomal localization in Fugu and Tetraodon nigroviridis. Chromosome Res (2000) 0.84
Orchestrated transcription of key pathways in Arabidopsis by the circadian clock. Science (2000) 12.35
Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science (1981) 9.64
A strategy for probing the function of noncoding RNAs finds a repressor of NFAT. Science (2005) 9.25
Mop3 is an essential component of the master circadian pacemaker in mammals. Cell (2000) 8.72
Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science (1973) 7.47
Homologous Serum Jaundice. Br Med J (1946) 6.30
A cluster of phosphorylation sites on the cyclic AMP-regulated nuclear factor CREB predicted by its sequence. Nature (1989) 5.89
Isolating "uncultivable" microorganisms in pure culture in a simulated natural environment. Science (2002) 5.70
Emr, an Escherichia coli locus for multidrug resistance. Proc Natl Acad Sci U S A (1992) 5.30
Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature (1983) 5.20
Association between early-onset Parkinson's disease and mutations in the parkin gene. N Engl J Med (2000) 4.98
The PAS superfamily: sensors of environmental and developmental signals. Annu Rev Pharmacol Toxicol (2000) 4.79
Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology (1983) 4.67
Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J Bacteriol (2001) 4.49
A comparison of the Celera and Ensembl predicted gene sets reveals little overlap in novel genes. Cell (2001) 4.36
Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature (1995) 4.24
Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol (2000) 4.17
Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. Annu Rev Neurosci (1983) 3.98
Results of a randomized trial of partner notification in cases of HIV infection in North Carolina. N Engl J Med (1992) 3.80
Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature (2013) 3.69
The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization. J Comp Neurol (1992) 3.53
Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell (1991) 3.28
Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci U S A (2001) 3.23
Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron (1998) 3.08
Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study. Lancet (2001) 3.06
Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet (2000) 3.04
EmrR is a negative regulator of the Escherichia coli multidrug resistance pump EmrAB. J Bacteriol (1995) 2.99
Designing surfaces that kill bacteria on contact. Proc Natl Acad Sci U S A (2001) 2.93
A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother (2000) 2.91
Molecular basis of the little mouse phenotype and implications for cell type-specific growth. Nature (1993) 2.83
Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit, HIF3alpha. Gene Expr (1998) 2.82
Coupling of hormonal stimulation and transcription via the cyclic AMP-responsive factor CREB is rate limited by nuclear entry of protein kinase A. Mol Cell Biol (1993) 2.79
Diversity of Conus neuropeptides. Science (1990) 2.78
Use of ichip for high-throughput in situ cultivation of "uncultivable" microbial species. Appl Environ Microbiol (2010) 2.77
Peptide neurotoxins from fish-hunting cone snails. Science (1985) 2.77
Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5'-methoxyhydnocarpin, a multidrug pump inhibitor. Proc Natl Acad Sci U S A (2000) 2.71
Expression cloning of a human corticotropin-releasing-factor receptor. Proc Natl Acad Sci U S A (1993) 2.70
Immunohistochemical identification of neurons in the paraventricular nucleus of the hypothalamus that project to the medulla or to the spinal cord in the rat. J Comp Neurol (1982) 2.61
High efficiency vectors for cosmid microcloning and genomic analysis. Gene (1989) 2.55
A habitable fluvio-lacustrine environment at Yellowknife Bay, Gale crater, Mars. Science (2013) 2.50
Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour. Nature (1982) 2.44
Characterization of a bipartite activator domain in transcription factor CREB. Cell (1990) 2.41
Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature (1986) 2.29
Paraventricular nucleus: a site for the integration of neuroendocrine and autonomic mechanisms. Neuroendocrinology (1980) 2.24
The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat. Brain Res (1982) 2.23
Activins are expressed early in Xenopus embryogenesis and can induce axial mesoderm and anterior structures. Cell (1990) 2.22
Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease. Lancet (1997) 2.16
Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci U S A (1994) 2.14
Rapid regression of uterine leiomyomas in response to daily administration of gonadotropin-releasing hormone antagonist. Fertil Steril (1993) 2.09
Operating conditions for ocular surgery under general anaesthesia: an eccentric problem. Eye (Lond) (2006) 2.06
Corticotropin releasing factor receptors and their ligand family. Ann N Y Acad Sci (1999) 2.04
CRF antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat. Psychopharmacology (Berl) (1991) 2.04
The organization of forebrain afferents to the paraventricular and supraoptic nuclei of the rat. J Comp Neurol (1983) 2.03
A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J Neurosci (1994) 2.02
Bacteria lacking a multidrug pump: a sensitive tool for drug discovery. Proc Natl Acad Sci U S A (1998) 2.01
Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus. J Comp Neurol (1988) 1.99
Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science (1996) 1.91
Increased frequency of rheumatoid factor precursor B lymphocytes after immunization of normal adults with tetanus toxoid. Clin Exp Immunol (1983) 1.88
Synthetic competitive antagonists of corticotropin-releasing factor: effect on ACTH secretion in the rat. Science (1984) 1.87
Posture-based motion planning: applications to grasping. Psychol Rev (2001) 1.87
Chemical and biological characterization of corticotropin releasing factor. Recent Prog Horm Res (1983) 1.86
Expanded profile of the SHAFT syndrome. J Hand Surg Am (1998) 1.84
Transgenic mice with inducible dwarfism. Nature (1989) 1.84
Requirement for Brn-3.0 in differentiation and survival of sensory and motor neurons. Nature (1996) 1.84
Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor. Endocrinology (1993) 1.83
A search for Bordetella pertussis infection in university students. Clin Infect Dis (1992) 1.83
Corticotropin releasing factor produces behavioural activation in rats. Nature (1982) 1.82
Primary structure of corticotropin-releasing factor from ovine hypothalamus. Proc Natl Acad Sci U S A (1981) 1.78
Development and survival of the endocrine hypothalamus and posterior pituitary gland requires the neuronal POU domain factor Brn-2. Genes Dev (1995) 1.78
P-Lim, a LIM homeodomain factor, is expressed during pituitary organ and cell commitment and synergizes with Pit-1. Proc Natl Acad Sci U S A (1995) 1.77
Corticotropin releasing factor decreases postburst hyperpolarizations and excites hippocampal neurons. Science (1983) 1.77
Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study. J Neurosci (1985) 1.77
The organization of projections from the central nucleus of the amygdala to brainstem sites involved in central autonomic regulation: a combined retrograde transport-immunohistochemical study. Brain Res (1984) 1.75
Modulation of urocortin-induced hypophagia and weight loss by corticotropin-releasing factor receptor 1 deficiency in mice. Endocrinology (2000) 1.72
Stimulation of noradrenergic sympathetic outflow by calcitonin gene-related peptide. Nature (1983) 1.70
Somatostatin. Recent Prog Horm Res (1975) 1.67
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Type 1 interleukin-1 receptor in the rat brain: distribution, regulation, and relationship to sites of IL-1-induced cellular activation. J Comp Neurol (1995) 1.66
Age and alarm symptoms do not predict endoscopic findings among patients with dyspepsia: a multicentre database study. Gut (2001) 1.66
Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J Neurosci (1994) 1.65
Cloning of a second type of activin receptor and functional characterization in Xenopus embryos. Science (1992) 1.64